IL6 and COVID-19: In this study, it was found that COVID-19 patients with chronic CVD and continued use of statins or RAASI had lower plasma concentrations of IL-6 than COVID-19 patients with no co-morbidities, despite their more advanced age and more prevalent immunosuppressive conditions.